Over 30 Years Experience
Expert In Vivo Efficacy Testing for a wide variety of human diseases

Browse Our Services by Category:

WBI’s specialized In Vivo Efficacy Testing Services cover four major disease categories – Autoimmune and Inflammatory Diseases (including a separate category for Rheumatoid Arthritis), Cancer, Bacterial Infection and Pain. Complementary services include Pharmacokinetics (PK), Toxicity and Support Services.

Washington Biotechnology, Inc. (WBI) is a leading In Vivo Services Contract Research Organization (CRO) for drug development.

For over 25 years we have provided our global biopharmaceutical clients with rapidly scheduled, accurate and cost-effective efficacy testing services.

Our clients drive innovation. We feel privileged to serve them in advancing treatments for human disease. In our role as CRO Partner, we are committed to the highest standards of science and project management.

Learn More